ArticleBMJ open2024

Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20).

Masahiro Sekimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.